Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

European ADRs Move Higher in Monday Trading

06/21/2021 | 11:14am EDT


© MT Newswires 2021
All news about BIONTECH SE
12:46pSTREET COLOR : Efficacy of Pfizer/BioNTech COVID-19 Vaccine Falls to 84% From 96..
MT
12:01pASTRAZENECA : Pfizer raises 2021 COVID-19 vaccine sales forecast to $33.5 billio..
RE
11:06aGLOBAL MARKETS LIVE : Apple, Alphabet, Facebook, Pfizer, McDonald's...
10:08aPFIZER : hikes 2021 outlook after vaccine boosts sales, profit
AQ
10:01aPFIZER : Reports Higher Second-Quarter Results as COVID-19 Vaccine Gives Boost, ..
MT
09:19aToday on Wall Street: Better-than-expected earnings ahead of the Fed
08:51aPFIZER : hikes Covid vaccine sales forecast by almost a third to $33.5bn
AQ
08:45aPFIZER : Lifts 2021 Guidance For COVID-19 Vaccine Sales
MT
02:05aLegal wrangles hold up U.S. vaccine donations to India
RE
07/27BIONTECH : AC Immune to Acquire Affiris' Vaccine Candidate Portfolio, Gets New I..
MT
More news
Financials
Sales 2021 12 451 M 14 701 M 14 701 M
Net income 2021 7 102 M 8 385 M 8 385 M
Net cash 2021 7 718 M 9 113 M 9 113 M
P/E ratio 2021 8,45x
Yield 2021 -
Capitalization 58 030 M 68 592 M 68 513 M
EV / Sales 2021 4,04x
EV / Sales 2022 4,18x
Nbr of Employees 2 200
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | BNTX | US09075V1026 | MarketScreener
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 240,27 €
Average target price 155,21 €
Spread / Average Target -35,4%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE248.38%68 592
GILEAD SCIENCES, INC.18.31%86 451
WUXI APPTEC CO., LTD.28.80%64 659
REGENERON PHARMACEUTICALS20.26%60 167
VERTEX PHARMACEUTICALS-14.17%52 511
GENMAB A/S11.86%28 658